190 related articles for article (PubMed ID: 6151151)
21. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
[TBL] [Abstract][Full Text] [Related]
22. Effects of losartan, somatostatin and losartan plus somatostatin on portal hemodynamics and renal functions in cirrhosis.
Hülagü S; Sentürk O; Erdem A; Ozgür O; Celebi A; Karakaya AT; Seyhogullari M; Demirci A
Hepatogastroenterology; 2002; 49(45):783-7. PubMed ID: 12063990
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological treatment of portal hypertension.
González-Abraldes J; Bosch J; García-Pagán JC
Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
[TBL] [Abstract][Full Text] [Related]
24. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
26. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat.
Jenkins SA; Devitt P; Day DW; Baxter JN; Shields R
Digestion; 1986; 33(3):126-34. PubMed ID: 2868955
[TBL] [Abstract][Full Text] [Related]
27. Colchicine treatment effects on liver cirrhosis assessed by liver blood flow measurements.
Tăpălagă D; Dumitraşcu D; Cotul S; Stanciu L; Tamaş S
Med Interne; 1986; 24(1):69-73. PubMed ID: 3704505
[TBL] [Abstract][Full Text] [Related]
28. Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flow.
Zervos EE; Goode SE; Rosemurgy AS
Am Surg; 1998 Jan; 64(1):71-5; discussion 75-6. PubMed ID: 9457041
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.
Villanueva C; Planella M; Aracil C; López-Balaguer JM; González B; Miñana J; Balanzó J
Am J Gastroenterol; 2005 Mar; 100(3):624-30. PubMed ID: 15743361
[TBL] [Abstract][Full Text] [Related]
30. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.
Wahren J; Eriksson LS
Scand J Gastroenterol Suppl; 1986; 119():103-8. PubMed ID: 2876492
[TBL] [Abstract][Full Text] [Related]
31. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.
Piscaglia F; Zironi G; Gaiani S; Mazziotti A; Cavallari A; Gramantieri L; Valgimigli M; Bolondi L
Hepatology; 1999 Jul; 30(1):58-64. PubMed ID: 10385639
[TBL] [Abstract][Full Text] [Related]
32. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients.
Hadengue A; Lebrec D; Moreau R; Sogni P; Durand F; Gaudin C; Bernuau J; Belghiti J; Gayet B; Erlinger S
Hepatology; 1993 Feb; 17(2):175-8. PubMed ID: 8428714
[TBL] [Abstract][Full Text] [Related]
33. [Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis].
Fedulenkova LV
Eksp Klin Gastroenterol; 2009; (5):130-7. PubMed ID: 20201315
[TBL] [Abstract][Full Text] [Related]
34. Circulatory effects of somatostatin in anesthetized man.
Tydén G; Samnegård H; Thulin L; Muhrbeck O; Efendić S
Acta Chir Scand; 1979; 145(7):443-46. PubMed ID: 161458
[TBL] [Abstract][Full Text] [Related]
35. [Dosage dependence of the effect of somatostatin on human splanchnic blood flow].
Keller U; Sonnenberg GE; Kayasseh L; Gyr K; Perruchoud A
Schweiz Med Wochenschr; 1979 Apr; 109(16):595-6. PubMed ID: 432587
[TBL] [Abstract][Full Text] [Related]
36. [Somatostatin and ventricular function in liver cirrhosis].
de la Villa FM; Solano López D; Bóveda J; Urrengoetxea J; Martínez Odriozola P; Bilbao Goitia P; Franco Vicario R
Rev Clin Esp; 1990 Feb; 186(2):58-62. PubMed ID: 1970439
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure.
Jenkins SA; Nott DM; Baxter JN
HPB Surg; 1998; 11(1):13-21. PubMed ID: 9830576
[TBL] [Abstract][Full Text] [Related]
38. Circulation times in the splanchnic and hepatic beds in alcoholic liver disease.
Kotelanski B; Groszmann R; Cohn JN
Gastroenterology; 1972 Jul; 63(1):102-11. PubMed ID: 5055736
[No Abstract] [Full Text] [Related]
39. [Influence of ascites on splanchnic and systemic hemodynamics in patients with alcoholic cirrhosis].
Cereda JM; Braillon A; Ozier Y; Moreau R; Gaudin C; Lebrec D
Gastroenterol Clin Biol; 1989 May; 13(5):495-8. PubMed ID: 2753286
[TBL] [Abstract][Full Text] [Related]
40. Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man.
Jenkins SA; Baxter JN; Corbett WA; Shields R
Br J Surg; 1985 Dec; 72(12):1009-12. PubMed ID: 2867802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
